| [1] Qi L,Bellail AC,Rossi MR,et al. Heterogeneity of primary glioblastoma cells in the expression of caspase-8 and the response to TRAIL-induced apoptosis[J].Apoptosis,2011,16(11): 1150-1164.[2] 齐 玲,沈 楠,王玮瑶,等. SENP蛋白在胶质瘤中表达与临床病理分级相关性[J]. 中国公共卫生,2015,31 (9): 1219-1221.[3] 范阳华,叶敏华,吴 雷,等.人脑胶质瘤中RSUME的SUMO化与 HIF-1α/VEGF 通路的相关性[J]. 西安交通大学学报:医学版,2015,36(4):472-478.[4] Bellail AC,Olson JJ,Hao C.SUMO1 modification stabilizes CDK6 protein and drives the cell cycle and glioblastoma progression[J].Nat Commun,2014,23(5):4234.[5] González-Santamaría J,Campagna M,Ortega-Molina A,et al. Regulation of the tumor suppressor PTEN by SUMO[J].Cell Death Dis,2012,27(3):e393.[6] Qin Y,Bao H,Pan Y,et al. SUMOylation alterations are associated with multidrug resistance in hepatocellular carcinoma[J].Mol Med Rep,2014,9(3):877-881.[7] Lee JS,Thorgeirsson SS. Genome-scale profiling of gene expression in hepatocellular carcinoma: classification,survival prediction,and identification of therapeutic targets[J].Gastroenterology,2004,127(5 Suppl 1): S51-55.[8] Han JY,Lee GK,Yoo SY,et al. Association of SUMO1 and UBC9 genotypes with tumor response in non-small-celllung cancer treated with irinotecan-based chemotherapy[J].Pharmacogenomics J,2010,10(2):86-93.[9] Hsieh YL,Kuo HY,Chang CC,et al. Ubc9 acetylation modulates distinct SUMO target modification and hypoxia response[J].EMBO J,2013,32(6):791-804.[10] Cao Q,Li YY,He WF,et al. Interplay between microRNAs and the STAT3 signaling pathway in human cancers[J].Physiol Genomics,2013,45(24):1206-1214.[11] Sozen S,Horozoglu C,Bireller ES,et al. Association of SUMO4 M55V and -94ins/del gene variants with type-2 diabetes[J].In Vivo 2014,28(5):919-923.[12] Sriramachandran AM,Dohmen RJ. SUMO-targeted ubiquitin ligases[J]. Biochim Biophys Acta,2014,1843(1):75-85.[13] Yang W,Wang L,Roehn G,et al. Small ubiquitin-like modifier 1-3 conjugation[corrected] is activated in human astrocytic brain tumors and is required for glioblastoma cell survival[J]. Cancer Sci,2013,104(1):70-77.[14] Johnson ES. Protein modification by SUMO[J]. Annu Rev Biochem,2004,73:355-382.[15] 齐 玲,于洪泉,丁丽娟,等. Caspase-8在胶质母细胞瘤抵抗TRAIL诱导凋亡中的作用[J]. 吉林大学学报:医学版,2011,37(4): 612-616.[16] Li Y,Kong Y,Zhou Z,et al. The HECTD3 E3 ubiquitin ligase facilitates cancer cell survival by promoting K63-linked polyubiquitination of caspase-8[J].Cell Death Dis,2013,28(4):e935.[17] Delfino DV,Spinicelli S,Pozzesi N,et al. Glucocorticoid-induced activation of caspase-8 protects the glucocorticoid-induced protein Gilz from proteasomal degradation and induces its binding to SUMO-1 in murine thymocytes[J]. Cell Death Differ,2011,18(1):183-190.[18] 王新军,杨如意,周少龙,等.胶质瘤相关性癫痫致痫灶组织中高迁移率族蛋白B1的表达[J].郑州大学学报:医学版,2015,50(5):634-637.[19] 王凤伟,牛光明,张鹏远,等.脑胶质瘤组织中Beclin-1的表达及与预后的关系[J].郑州大学学报:医学版,2014,49(4):472-475. |
